top of page
About Us

MVRIX

Motivated Ventures in Research, Innovation, and eXcellence

Our company was founded in 2021, and since then MVRIX has focused on protein engineering–based therapeutics, successfully establishing three core platform technologies in a short time.We continue to grow rapidly through active collaboration with companies, universities, and research institutes. Our mission is to solve the challenges of complex drug development with innovative technologies and bring positive change to people’s lives.

about overview.png

MVRIX at a glance

To turn the potential of new therapies into reality, we speak with data and prove with results.

20
+
Partners

Extensive R&D network

80
Patents

~80 IP assets secured

9.8
B
Funded(KRW)

KRW 9.8B raised & grants

3
Platform Technology

3 platforms technologies built since 2021

물방울

Our Motives

We are the people who question and seek answers in the face of change.

Our Vision

We go beyond the limits to open up new possibilities

We go beyond the limits of conventional medicines to open new possibilities.

Core Values

1.Innovation.png

COMMITMENT TO INNOVATION

We drive progress and lead innovation across multiple therapeutic areas.

2.Solution.png

Versatile Solutions

We respond to new needs and opportunities with the best-fit solutions.

3.Impact.png

Positive Impact

We create meaningful change in people’s lives through positive impact.

Credentials & Recognition

Our certifications and recognitions from diverse institutions demonstrate that we are a ready and reliable partner.

Key Milestones
2025.05
MBT-002 pipeline L/O (Eyegene Inc.)
2025.04
Selected for the 2025 KDDF Drug Development Project
2025.04
Selected for the 2025 Bio-Medical Technology Development Program
2025.03
Navibody Platform Selected for the Super Gap Startup 1000+ Project (DIPS)
2023.04
Selected for R&D Project for Health and Medical Technology
2022.04
Certified Corporate Research Institute
2021.06
Selected for the 2021 Early Startup Package
2021.01
Founded
bottom of page